Abstract
Tujia ethnomedicine is an important part of the national medicine system in China. Two Panax japonicus (Araliaceae) varietals known as Bai San Qi and Kou Zi Qi in Tujia ethnomedicine are of interest for further study due to their traditional use, biological effects and potential use in clinical applications. The plants have traditionally been used to treat weakness, fatigue and rheumatism for over a thousand years. As Bai San Qi and Kou Zi Qi are members of the genus Panax, both contain significant levels of saponins. Saponins have been shown to have a variety of bioactivities including, antiinflammatory, anti-tumor and α-glucosidase inhibitory activities. Thus far, 109 different saponins have been isolated from and identified in the two plants. This review describes, classifies and provides information on reported biological activities and characteristic 1H-NMR and 13C-NMR signals for the saponins found in the two species. It aims to decrease the difficulties in structure elucidation of typical saponins and provides instruction and theoretical basis for further research of the two plants.
Keywords: Araliaceae, Panax japonicus, Triterpenoid saponins, Tujia ethnomedicine, zhu jie shen, zhu zi shen.
Graphical Abstract
Current Traditional Medicine
Title:Triterpenoid Saponins from Two Panax japonicus Varietals Used in Tujia Ethnomedicine
Volume: 1 Issue: 2
Author(s): Yang Liu, Michael Chan, Jianhua Huang, Bin Li, Wen Ouyang, Caiyun Peng, Duanfang Liao and Wei Wang
Affiliation:
Keywords: Araliaceae, Panax japonicus, Triterpenoid saponins, Tujia ethnomedicine, zhu jie shen, zhu zi shen.
Abstract: Tujia ethnomedicine is an important part of the national medicine system in China. Two Panax japonicus (Araliaceae) varietals known as Bai San Qi and Kou Zi Qi in Tujia ethnomedicine are of interest for further study due to their traditional use, biological effects and potential use in clinical applications. The plants have traditionally been used to treat weakness, fatigue and rheumatism for over a thousand years. As Bai San Qi and Kou Zi Qi are members of the genus Panax, both contain significant levels of saponins. Saponins have been shown to have a variety of bioactivities including, antiinflammatory, anti-tumor and α-glucosidase inhibitory activities. Thus far, 109 different saponins have been isolated from and identified in the two plants. This review describes, classifies and provides information on reported biological activities and characteristic 1H-NMR and 13C-NMR signals for the saponins found in the two species. It aims to decrease the difficulties in structure elucidation of typical saponins and provides instruction and theoretical basis for further research of the two plants.
Export Options
About this article
Cite this article as:
Liu Yang, Chan Michael, Huang Jianhua, Li Bin, Ouyang Wen, Peng Caiyun, Liao Duanfang and Wang Wei, Triterpenoid Saponins from Two Panax japonicus Varietals Used in Tujia Ethnomedicine, Current Traditional Medicine 2015; 1 (2) . https://dx.doi.org/10.2174/2215083801999151029101246
DOI https://dx.doi.org/10.2174/2215083801999151029101246 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Endothelin Receptor Antagonists as Disease Modifiers in Systemic Sclerosis
Inflammation & Allergy - Drug Targets (Discontinued) Anticoagulation in Patients with Heparin-Induced Thrombocytopenia undergoing Percutaneous Coronary Angiography and Interventions
Current Pharmaceutical Design Infants and Children with Tachycardia: Natural History and Drug Administration
Current Pharmaceutical Design Effects of Endothelins on Cardiac and Vascular Cells: New Therapeutic Target for the Future?
Current Vascular Pharmacology CD93: Recent Advances and Implications in Disease
Current Drug Targets Primary and Secondary Stroke Prevention with Antiplatelet Drugs
Current Pharmaceutical Design Beneficial Role of Vitexin and Isovitexin Flavonoids in the Vascular Endothelium and Cardiovascular System
Current Nutraceuticals Stem Cells in Cardiovascular Regeneration: From Preservation of Endogenous Repair to Future Cardiovascular Therapies
Current Pharmaceutical Design Nitroimidazole Radiopharmaceuticals in Bioimaging: Part I: Synthesis and Imaging Applications
Current Radiopharmaceuticals Rho Kinase and Angiogenesis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Hippocampal Autophagic Machinery is Depressed in the Absence of the Circadian Clock Protein PER1 that may Lead to Vulnerability During Cerebral Ischemia
Current Neurovascular Research Voltage-Gated Sodium Channel Blockers for the Treatment of Chronic Pain
Current Topics in Medicinal Chemistry The Therapeutic Potential of Angiotensin-(1-7) as a Novel Renin- Angiotensin System Mediator
Mini-Reviews in Medicinal Chemistry Pathogenetic Pathways of Cardiorenal Syndrome and their Possible Therapeutic Implications
Current Pharmaceutical Design Editorial (Thematic Issue: Modifying Cardiovascular Risk Factors: Current Opinion and Future Trends)
Current Pharmaceutical Design The Impact of Hypertension as a Road to Heart Failure with Preserved Ejection Fraction: Diagnostic Value of Two-Dimensional Speckle Tracking Echocardiography for the Early Impairment of Left Atrial-Left Ventricular-Arterial Coupling
Current Hypertension Reviews The Development of Cannabinoid CBII Receptor Agonists for the Treatment of Central Neuropathies
Central Nervous System Agents in Medicinal Chemistry Role of Stromal-Derived Factor-1 in Mesenchymal Stem Cell Paracrinemediated Tissue Repair
Current Stem Cell Research & Therapy Effect of β-Blockers on Perioperative Myocardial Ischemia in Patients Undergoing Noncardiac Surgery
Current Drug Targets LINE-1 Methylation is Associated with an Increased Risk of Ischemic Stroke in Men
Current Neurovascular Research